Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.42 - $2.23 $4.42 Million - $6.94 Million
3,112,500 New
3,112,500 $5.91 Million
Q4 2019

Feb 14, 2020

SELL
$6.75 - $11.15 $2.82 Million - $4.65 Million
-417,064 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$8.57 - $10.72 $2.1 Million - $2.63 Million
245,364 Added 142.9%
417,064 $3.59 Million
Q2 2019

Aug 14, 2019

BUY
$7.58 - $10.0 $1.3 Million - $1.72 Million
171,700 New
171,700 $1.41 Million
Q4 2017

Feb 14, 2018

SELL
$20.9 - $49.36 $1.08 Million - $2.55 Million
-51,600 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$39.62 - $46.17 $2.04 Million - $2.38 Million
51,600
51,600 $2.19 Million

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $95.8M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.